Short-Course Antimicrobial Therapy of Streptococcal Pharyngitis

Abstract

Get full access to this article

View all access options for this article.

References

1. Armstrong GL , Pinner RW . Outpatient visits for infectious diseases in the United States, 1980 through 1996. Arch Intern Med 1999;159:2531-2536.

2. Cherry JD . Pharyngitis (pharyngitis, tonsillitis, tonsillopharyngitis, and nasopharyngitis). In: Feigin RD , Cherry JD , eds. Textbook of Pediatric Infectious Diseases. Philadelphia: Saunders; 1998:148-156.

3. Brink WR , Rammelkamp CH , Dennsy FW , Wannamaker LAW . Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis. Am JMed 1951;10:300-308.

4. Shulman ST . Complication of streptococcal pharyngitis. Pediatr Infect Dis J 1994;13 (Suppl):S70-S74.

5. Gooch WM . Potential infectious disease complications of upper respiratory tract infections. Pediatr Infect Disj 1998;17 (Suppl):S79-S82.

6. Bisno AL , Gerber MA , Gwaltney JMJr , et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002;35:113-125.

7. Pichichero ME , Casey JR , Mayes T , et al. Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatr Infect Dis J 2000;19:917-923.

8. Pichichero ME , Green JL , Francis AB , et al. Recurrent group A streptococcal tonsillopharyngitis. Pediatr Infect Disj 1998;17:809-815.

9. Kaplan EL , Johnson DR . Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics. 2001;108:1180-1186.

10.

10. Pichichero ME , Margolis PA . A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Disj 1991;10:275-281.

11.

11. Deeter RG , Kalman DL , Rogan MP , Chow SC . Therapy for pharyngitis and tonsillitis caused by group A betahemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V. Clin Ther 1992;14:740-754.

12.

12. Esposito S , Noviello S , lanniello F , D'Errco G . Short-course therapy with cefaclor for treatment of streptococcal pharyngitis. Int JAntimicrob Agents. 2001;18:341-345.

13.

13. Esposito S , Marchisio P , Bosis S , et al. Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children. Int J Antimicrob Agents. 2002;20:28-33.

14.

14. Adam D , Hostalek U , Troster K . Fiveday cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. Infection. 1995;23(Suppl 2):S83-S86.

15.

15. Adam D , Scholz H , Helmerking M . Comparison of short-course (5-day) cefuroxime axetil with a standard 10-day oral penicillin V regimen in the treatment of tonsillopharyngitis.JAntimicrob Chemother 2000;45(Suppl):23-30.

16.

16. Boccazzi A , Tonelli P , De'Angelis M , et al. Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. Pediatr Infect Disj 2000;19:963-967.

17.

17. Aujard Y , Boucot I , Brahimi N , et al. Comparative efficacy and safety of 4-day cefuroxime axetil and 10-day penicillin treatment of group A betahemolytic streptococcal pharyngitis in children. Pediatr Infect Dis j 1995; 14:295-300.

18.

18. Mehra S , van Moerkerke M , Welck J , et al. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Disj 1998;17:452-457.

19.

19. Adam D , Scholz H , Helmerking M . Short-course antibiotic treatment of 4,782 culture-proven cases of group A streptococccal tonsillopharyngitis and incidence of poststreptocccal se-quelae.JInfect Dis 2000;182:509-516.

20.

20. Portier H , Filipecki J , Weber P , et al. Five-day clarithromycin modified release versus 10-day penicillin V for group A streptococcal pharyngitis: a multicenter, open-label, randomized study. J Antimicrob Chemother. 2002; 49:337-344.

21.

21. Bisno AL , Acute pharyngitis: etiology and diagnosis. Pediatrics. 1996;97(6 Pt 2):949-954.

22.

22. Bisno AL , Peter GS , Kaplan EL

Diagnosis of strep throat in adults: are clinical criteria really good enough?

Clin Infect Dis 2002;35:126-129.

23.

23. Dowell SF , Schwartz B , Phillips WR , and the Pediatric URI Consensus Team . Appropriate use of antibiotics for URIs in children: Part II. Cough, pharyngitis and the common cold. Am Fam Physician. 1998;58:1113-1123.

24.

24. Block SL , Hedrick JA , Harrison CJ , et al. Increasing rates of resistance in acute otitis media. [abstract] In: Programs and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. September 26-29, 1999. www.asmusa.org.

25.

25. Mascini EM , Jansze M , Schouls LM , et al. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents. 2001;18:395-398.

26.

26. Russell NE , Pachorek RE . Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes. Ann Pharmacother. 2000; 34:936-939.

27.

27. Murphy ML , Pichichero ME . Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal.infection (PANDAS). Arch Pediatr Adolesc Med 2002;156:356-361.

28.

28. Steigbigel NH . Macrolides and clindamycin. In: Mandell GL , Bennett JE , Dolin R , eds. Principles and Practice of Infectious Diseases, ed. 5. Philadelphia: Churchill Livingstone; 2000:366-382.

29.

29. Kaplan EL , Johnson DR , Del Rosario MC , Horn DL . Susceptibility of group A beta-hemolytic streptococci to 13 antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J. 1999;18:1069-1072.

30.

30. York MK , Gibbs L , Perdreau-Remington F , Brooks GF . Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J Clin Microbiol. 1999;37:1727-1731.

31.

31. Martin JM , Green M , Barbadora KA , Wald ER . Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002;346:1200-1206.

32.

32. Orden B , Perez-Trallero E , Montes M , Martinez R . Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr Infect Dis J. 1998;17:470-473.

33.

33. Cornaglia G , Ligozzi M , Mazzariol A , et al. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis 1998; 27(Suppl 1):S87-S92.

34.

34. Paradise JL , Bluestone CD , Colborn DK , et al. Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics. 2002;110:7-15.

35.

35. Stollerman GH . Rheumatic fever in the 21st century. Clin Infect Dis 2001; 33:806-814.

36.

36. Manyemba J , Mayosi BM . Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 2002;(3):CD002227-CD002227.

37.

37. Brook I . Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg 1995;121:1405-1409.

38.

38. Sanders C , Nelson G , Sanders E . Bacterial interference: II. Epidemiological determinants of the antagonistic activity of the normal throat flora against Group A streptococci. Infect Immun. 1977;16:599-603.

39.

39. Block SL , Hedrick JA , Tyler RD . Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Disj 1992;11:919-925.

40.

40. Roos K , Grahn E , Holm SE , et al. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol. 1993;25:141-148.

41.

41. Falck G , Grahn-Hakansson E , Holm SE , et al. Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol. 1999;119:944-948.

42.

42. Roos K , Holm SE , Grahn-Hakansson E , Lagergren L . Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis-a randomized placebo-controlled multicentre study. Scand J Infect Dis 1996;28:459-462.

43.

43. Bergman A , Werner R . Failure of children to receive penicillin by mouth. NEngl JMed 1963;268:1334-1338.

44.

44. Gerber MA , Randolph MF , Chanatry J , et al. Five vs 10 days of penicillin V therapy for streptococcal pharyngitis. Am JDis Child. 1987;141:224-227.

45.

45. Schwartz RH , Wientzen RL Jr , Pedreira F , et al. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of 7 vs 10 days' therapy. JAMA. 1981;246:1790-1795.

46.

46. Shvartzman P , Tabenkin H , Rosentzwaig A , Dolginov F . Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ. 1993; 306(6886):1170-1172.

47.

47. Feder HM Jr , Gerber MA , Randolph MF , et al. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics. 1999;103:47-51.

48.

48. Chomarat M , Panteix G , Guillaumond B , Dubreuil C . Tonsillar diffusion kinetics of amoxycillin after oral administration of 1 g to adults. Eur J Drug Metab Pharmacokinet. 1997; 22:141-144.

49.

49. Stjernquist-Desatnik A , Samuelsson P , Walder M . Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J Laryngol Otol. 1993; 107:309-312.

50.

50. Peyramond D , Portier H , Geslin P , Cohen R . Six-day amoxicillin versus 10-day penicillin V for group A betahaemolytic streptococcal acute tonsillitis in adults: A French multicentre, open-label, randomized study. The French Study Group Clamorange. Scand J Infect Dis 1996;28:497-501.

51.

51. Nemeth MA , Mc Carty J , Gooch WM III , et al. Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. Clin Ther 1999; 21:1873-1881.

52.

52. Nemeth MA , Gooch WM III , Hedrick J , et al. (Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis. Clin Ther: 1999;21:1525-1532.

53.

53. Pichichero ME , Gooch WM , Rodriguez W , et al. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Arch Ped iatr Adolesc Med 1994;148:1053-1060.

54.

54. Tack KJ , Henry DC , Gooch WM , et al. Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. Antimicrob Agents Chemother 1998;42:1073-1075.

55.

55. Mc Carty JM . Clarithromycin in the management of community-acquired pneumonia. Clin Ther: 2000;22:281-294.

56.

56. Still JG . Management of pediatric patients with groups A beta-hemolytic Streptococcus pharyngitis: treatment options. Pediatr Infect Dis J. 1995; 14(Suppl 3A):S57-S61.

57.

57. Pichichero ME , Gooch WM III . Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis. Pediatr Infect Disf 2000;19(Suppl 12):S171-S173.

58.

58. Tack KJ , Hedrick JA , Rothstein E , et al. A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group. Arch Pediatr Adolesc Med 1997;151:45-49.

59.

59. Portier H , Chavanet P , Waldner Combernoux A , et al. Five versus 10 days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Scand J Infect Dis 1994; 26:59-66.

60.

60. Schaad URS B , Kellerhals P , Altwegg M , and the Swiss Pharyngitis Study Group . Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. Pediatr Infect Dis J 2002;21:304-308.

61.

61. Cohen R , Reinert P , De La Rocque F , et al. Comparison of two dosages of azithromycin for 3 days versus penicillin V for 10 days in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Disj 2002;21:297-303.